Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1978-07-31
1980-08-05
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, 424180, 536 53, A61K 3700, C07C10352, A61K 3170
Patent
active
042162084
ABSTRACT:
N-Acyl derivatives of glucosamines made by linking an amino acid or oligopeptide having a m-di(2-chloroethyl)amino-L-phenylalanyl group, to the amino group of the glucosamines by a peptide bond, are endowed with strong anti-tumor action against transplanted neoplasma in animal. The compounds according to the present invention are of the general formula (I): ##STR1## where R.sub.1 is a hydrogen atom or an acetyl group,
REFERENCES:
Siggins et al., J.A.C.S. 1966, pp. 971-973.
Adam et al., Biochem. and Biophys. Res. Commun. 72, 1976, pp. 339-346.
Phillips Delbert R.
Proter S.p.A.
LandOfFree
N-Acyl derivatives of glucosamines having antitumor chemotherape does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-Acyl derivatives of glucosamines having antitumor chemotherape, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-Acyl derivatives of glucosamines having antitumor chemotherape will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2280323